A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Epilepsies, Partial
Interventions
DRUG

Levetiracetam 250 mg

"* Active Substance: Levetiracetam~* Pharmaceutical Form: Film-coated tablet~* Concentration: 250 mg~* Route of Administration: Oral Use"

DRUG

Levetiracetam 500 mg

"* Active Substance: Levetiracetam~* Pharmaceutical Form: Film-coated tablet~* Concentration: 500 mg~* Route of Administration: Oral Use"

OTHER

Placebo

"* Active Substance: Placebo~* Pharmaceutical Form: Film-coated tablet~* Concentration: 250 mg and 500 mg~* Route of Administration: Oral Use"

Trial Locations (37)

Unknown

Aichi-gun

Nagoya

Nayoga

Hirosaki

Chiba

Fukuoka

Kitakyushu

Kurume

Gifu

Fukuyama

Hiroshima

Asahikawa

Hakodate

Sapporo

Kobe

Kahoku-gun

Kagoshima

Kikuchi-gun

Kyoto

Sendai

Miyazaki

Nagaoka

Ōmura

Niigata

Okayama

Izumi

Neyagawa

Osaka

Suita

Shizuoka

Kawachi-gun

Kodaira

Tokyo

Toyama

Yamagata

Ube

Kobe

All Listed Sponsors
lead

UCB Japan Co. Ltd.

INDUSTRY

NCT00280696 - A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures | Biotech Hunter | Biotech Hunter